M&A / Deals RoosterBio and MineBio team up to expand MSC solutions access in China Pharmaceutical Business ReviewMineBio will supply RoosterBio's complete platform of products, having already obtained import clearance.M&A / DealsRead full story pharminent April 8, 2026 (Last updated: April 8, 2026) Pharmaceutical Business Review MineBio will supply RoosterBio’s complete platform of products, having already obtained import clearance. M&A / DealsRead full story Post navigation Previous: Halozyme and Vertex sign deal for Hypercon technologyNext: EU invests 30m to fight antimicrobial resistance Related Stories M&A / Deals BioMarin spends up to $490m for Alesta’s bone disease candidate pharminent August 19, 2026 M&A / Deals J&J hands lymphoma bispecific CAR T back to AbelZeta pharminent August 17, 2026 M&A / Deals Novo Nordisk and AWS form AI partnership to speed drug discovery pharminent August 17, 2026
